{"id":"https://openalex.org/W1556538175","doi":"https://doi.org/10.1007/bf03261840","title":"Anticoagulation Therapy for Patients with Non-Valvular Atrial Fibrillation","display_name":"Anticoagulation Therapy for Patients with Non-Valvular Atrial Fibrillation","publication_year":2012,"publication_date":"2012-08-28","ids":{"openalex":"https://openalex.org/W1556538175","doi":"https://doi.org/10.1007/bf03261840","mag":"1556538175","pmid":"https://pubmed.ncbi.nlm.nih.gov/22920047"},"language":"en","primary_location":{"id":"doi:10.1007/bf03261840","doi":"https://doi.org/10.1007/bf03261840","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf03261840","pdf_url":null,"source":{"id":"https://openalex.org/S151621711","display_name":"American Journal of Cardiovascular Drugs","issn_l":"1175-3277","issn":["1175-3277","1179-187X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Cardiovascular Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017089521","display_name":"Julian P. Casciano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Julian P. Casciano","raw_affiliation_strings":["eMAX Health Systems, LLC, White Plains, NY 10601, USA. juliancasciano@emaxhealth.net","eMAX Health Systems, LLC, White Plains, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eMAX Health Systems, LLC, White Plains, NY 10601, USA. juliancasciano@emaxhealth.net","institution_ids":[]},{"raw_affiliation_string":"eMAX Health Systems, LLC, White Plains, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020290782","display_name":"Daniel E. Singer","orcid":"https://orcid.org/0000-0001-6145-4848","observed_orcids":["https://orcid.org/0000-0001-6145-4848"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel E. Singer","raw_affiliation_strings":["Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA","Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113504119","display_name":"Winghan Jacqueline Kwong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162815","display_name":"Daiichi Sankyo (United States)","ror":"https://ror.org/055werx92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104626","https://openalex.org/I4210162815"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Winghan Jacqueline Kwong","raw_affiliation_strings":["Health Economics & Outcomes Research, Daiichi Sankyo, Inc, Parsipanny, New Jersey, USA","Health Economics & Outcomes Research, Daiichi Sankyo, Inc, Parsipanny, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics & Outcomes Research, Daiichi Sankyo, Inc, Parsipanny, New Jersey, USA","institution_ids":["https://openalex.org/I4210162815"]},{"raw_affiliation_string":"Health Economics & Outcomes Research, Daiichi Sankyo, Inc, Parsipanny, USA","institution_ids":["https://openalex.org/I4210162815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103765071","display_name":"Eben S. Fox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162815","display_name":"Daiichi Sankyo (United States)","ror":"https://ror.org/055werx92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104626","https://openalex.org/I4210162815"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eben S. Fox","raw_affiliation_strings":["New Product Planning, Daiichi Sankyo, Inc, Parsipanny, New Jersey, USA","New Product Planning, Daiichi Sankyo, Inc, Parsipanny, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Product Planning, Daiichi Sankyo, Inc, Parsipanny, New Jersey, USA","institution_ids":["https://openalex.org/I4210162815"]},{"raw_affiliation_string":"New Product Planning, Daiichi Sankyo, Inc, Parsipanny, USA","institution_ids":["https://openalex.org/I4210162815"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000856613","display_name":"Bradley C. Martin","orcid":"https://orcid.org/0000-0001-8402-3098","observed_orcids":["https://orcid.org/0000-0001-8402-3098"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley C. Martin","raw_affiliation_strings":["Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA","Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA","institution_ids":["https://openalex.org/I79620101"]},{"raw_affiliation_string":"Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, USA","institution_ids":["https://openalex.org/I79620101"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5017089521"],"corresponding_institution_ids":[],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.8712,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.86649084,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"12","issue":"5","first_page":"313","last_page":"323"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-valvular-atrial-fibrillation","display_name":"non-valvular atrial fibrillation","score":0.9509999752044678},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.8270000219345093},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.8629999756813049},{"id":"https://openalex.org/keywords/stroke-risk","display_name":"stroke risk","score":0.718999981880188},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chads2-score","display_name":"CHADS2 score","score":0.9459999799728394},{"id":"https://openalex.org/keywords/markov-decision-process","display_name":"Markov decision process","score":0.8050000071525574},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.746999979019165},{"id":"https://openalex.org/keywords/quality-adjusted-life-expectancy","display_name":"quality-adjusted life expectancy","score":0.8500000238418579},{"id":"https://openalex.org/keywords/clinical-decision-aids","display_name":"clinical decision aids","score":0.625}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.93720543384552},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8903354406356812},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.8708605766296387},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.658312201499939},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.591556191444397},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.5330119729042053},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4981679916381836},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4428379237651825},{"id":"https://openalex.org/C2776259030","wikidata":"https://www.wikidata.org/wiki/Q769508","display_name":"Bleed","level":2,"score":0.4260368347167969},{"id":"https://openalex.org/C11783203","wikidata":"https://www.wikidata.org/wiki/Q5478027","display_name":"Framingham Risk Score","level":3,"score":0.42149507999420166},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3991852402687073},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35312509536743164},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.26602381467819214},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.13616815209388733},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003661","descriptor_name":"Decision Support Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/bf03261840","doi":"https://doi.org/10.1007/bf03261840","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf03261840","pdf_url":null,"source":{"id":"https://openalex.org/S151621711","display_name":"American Journal of Cardiovascular Drugs","issn_l":"1175-3277","issn":["1175-3277","1179-187X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Cardiovascular Drugs","raw_type":"journal-article"},{"id":"doi:10.2165/11634150-000000000-00000","doi":"https://doi.org/10.2165/11634150-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11634150-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S151621711","display_name":"American Journal of Cardiovascular Drugs","issn_l":"1175-3277","issn":["1175-3277","1179-187X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal Cardiovascular Drugs","raw_type":"journal-article"},{"id":"pmid:22920047","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22920047","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of cardiovascular drugs : drugs, devices, and other interventions","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310058","display_name":"University of Arkansas","ror":"https://ror.org/05jbt9m15"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1486272503","https://openalex.org/W1508825876","https://openalex.org/W1522894564","https://openalex.org/W1804375307","https://openalex.org/W1963725401","https://openalex.org/W1966087026","https://openalex.org/W1993614294","https://openalex.org/W2011936209","https://openalex.org/W2014569663","https://openalex.org/W2037406584","https://openalex.org/W2045913143","https://openalex.org/W2058025443","https://openalex.org/W2060630424","https://openalex.org/W2062786076","https://openalex.org/W2066157763","https://openalex.org/W2071980470","https://openalex.org/W2073496233","https://openalex.org/W2074279287","https://openalex.org/W2074334843","https://openalex.org/W2083723075","https://openalex.org/W2084576139","https://openalex.org/W2085270509","https://openalex.org/W2089124341","https://openalex.org/W2089534375","https://openalex.org/W2090513638","https://openalex.org/W2106143461","https://openalex.org/W2112038989","https://openalex.org/W2116067858","https://openalex.org/W2116489124","https://openalex.org/W2117582884","https://openalex.org/W2120064023","https://openalex.org/W2124601103","https://openalex.org/W2126206943","https://openalex.org/W2131099415","https://openalex.org/W2144891869","https://openalex.org/W2158454439","https://openalex.org/W2159730165","https://openalex.org/W2164861810","https://openalex.org/W2415694803","https://openalex.org/W2418404450","https://openalex.org/W2546446487","https://openalex.org/W2745041403"],"related_works":["https://openalex.org/W2741663808","https://openalex.org/W2096908697","https://openalex.org/W2254034384","https://openalex.org/W7097417290","https://openalex.org/W1964685156","https://openalex.org/W2893569293","https://openalex.org/W2026781979","https://openalex.org/W2025295558","https://openalex.org/W2090513638","https://openalex.org/W2474834061"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}